The move comes at a time when Japan is wrestling with increasing healthcare costs brought on by its rising population of seniors the fastest-growing segment of the country’s population.
Through our agreement with IBM, Matria will become one of the first US disease management companies to offer these services to Japanese companies, said Parker Petit, Matria’s chairman and CEO.
In recent years, we’ve seen US employers embrace health enhancement and disease management services as a solution to their rising healthcare burdens, Mr Petit continued, We are very encouraged to see other healthcare systems and international employers recognize the benefits and improved outcomes that disease management can bring to their covered populations.
Healthcare expenditures in Japan are increasing due to the aging population and the rise of lifestyle-related diseases such as heart disease and diabetes, said Ellen Yoon, global health insurance manager for IBM. IBM’s collaboration with Matria will bring solutions which can help address the healthcare impact of these demographic changes.
Matria’s Total Health Enhancement Solution is a broad array of programs that address aspects of care ranging from wellness and prevention to disease management for chronic and high-cost diseases.
